U.S., Feb. 8 -- ClinicalTrials.gov registry received information related to the study (NCT06814522) titled 'Psilocybin-Assisted Therapy for Physician Well-Being and Burnout' on Feb. 01.
Brief Summary: Through an open-label study involving a small group of UCSD physicians experiencing burnout, the investigators will evaluate the feasibility, safety, and preliminary effectiveness of PAT to reduce burnout symptoms.
Study Start Date: April, 2025
Study Type: INTERVENTIONAL
Condition:
Burnout
Burnout, Healthcare Workers
Intervention:
DRUG: Psilocybin, [3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] dihydrogen phosphate
25 mg, single dose of synthetic psilocybin
Recruitment Status: NOT_YET_RECRUITING
Sponsor: University of California, San Die...